EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates

Danil D. Anikev, Anastasia Yu. Filippova, Olga I. Yarovaya, Serafim A. Tishchenko, Alla V. Pavlova, Alina A. Sonina, Kseniya S. Kovaleva, Mikhail V. Khvostov, Tatyana G. Tolstikova, Andrey Yu. Petrov, Nariman F. Salakhutdinov

Scientia Pharmaceutica · 31.07.2026 · 94 (3) · 63

DOI: 10.3390/scipharm94030063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 31.07.2026. Verfasst von Danil D. Anikev und 10 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Government of the Novosibirsk region.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon®, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon® were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.

Förderung

  • Russian Science Foundation
  • Government of the Novosibirsk region

Zitieren

APA

Anikev, D. D., Filippova, A. Y., Yarovaya, O. I., Tishchenko, S. A., Pavlova, A. V., Sonina, A. A., Kovaleva, K. S., Khvostov, M. V., Tolstikova, T. G., Petrov, A. Y., & Salakhutdinov, N. F. (2026). Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Scientia Pharmaceutica, 94(3), 63. https://doi.org/10.3390/scipharm94030063

Vancouver

Anikev DD, Filippova AY, Yarovaya OI, Tishchenko SA, Pavlova AV, Sonina AA, et al. Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Scientia Pharmaceutica. 2026;94(3):63. doi:10.3390/scipharm94030063

BibTeX
@article{Anikev2026,
  author = {Anikev, Danil D. and Filippova, Anastasia Yu. and Yarovaya, Olga I. and Tishchenko, Serafim A. and Pavlova, Alla V. and Sonina, Alina A. and Kovaleva, Kseniya S. and Khvostov, Mikhail V. and Tolstikova, Tatyana G. and Petrov, Andrey Yu. and Salakhutdinov, Nariman F.},
  title = {Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates},
  journal = {Scientia Pharmaceutica},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {63},
  doi = {10.3390/scipharm94030063}
}
Kostenlos starten →